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To assess the role of interleukin-12 (IL-12) and gamma interferon (IFN-g) in children with bacterial
meningitis, bioactive IL-12 (p70) and the inactive subunit p40 and IFN-g were measured in serum and
cerebrospinal fluid (CSF) from 35 children with bacterial meningitis and 10 control subjects. The production
of IFN-g is induced by IL-12 with tumor necrosis factor alpha (TNF-a) as a costimulator and inhibited by
IL-10. CSF concentrations of IL-12 p40 as well as those of IFN-g were markedly elevated, whereas IL-12 p70
was hardly detectable. Detectable CSF levels of IFN-g correlated positively with IL-12 p40 (r 5 0.40, P 5 0.02)
and TNF-a (r 5 0.46, P 5 0.04) but not with IL-6, IL-8, or IL-10. In contrast to CSF levels of TNF-a, IL-12,
and IL-10, those of IFN-g were significantly higher in patients with pneumococcal meningitis than in children
with meningitis caused by Haemophilus influenzae and Neisseria meningitidis, presumably because of a high CSF
TNF-a/IL-10 ratio in the former. We suggest that IL-12- and TNF-a-induced IFN-g production may contribute
to the natural immunity against microorganisms in the CSF compartment during the acute phase of bacterial
meningitis.
Proinflammatory cytokines (tumor necrosis factor alpha
[TNF-a], interleukin-6 [IL-6], IL-8, and gamma interferon
[IFN-g]) are involved in the pathophysiology of bacterial men-
ingitis (18). Recently, a novel cytokine with proinflammatory
effects has been described (10, 17, 26, 31). This cytokine, IL-12,
augments the host defense against bacteria, bacterial products,
and parasites. Bioactive IL-12 is a heterodimeric protein of 70
kDa (p70) which consists of 40-kDa (p40) and 35-kDa (p35)
subunits linked by a disulfide bond (17). IL-12 is produced
predominantly by macrophages/monocytes but also by B cells
(9) and polymorphonuclear leukocytes (4). It has been shown
to enhance the cytolytic activity of a number of effector cells,
including T cells, natural killer (NK) cells, lymphokine-acti-
vated killer cells, and macrophages. Furthermore, IL-12 also
increases the proliferation of activated NK and T cells and
stimulates the production of cytokines, such as IFN-g, granu-
locyte-macrophage colony-stimulating factor, and TNF-a (2, 5,
27). The release of IFN-g is costimulated by TNF-a and IL-1b
and inhibited by IL-10 (8, 28).
It has been proposed that IL-12 is involved in the early
development of an immune response against infectious agents.
Production of IL-12 contributes to the control of the host
response against infections with intracellular organisms such as
Listeria monocytogenes (14), Toxoplasma gondii (11), and
Leishmania major (1). IL-12-mediated protection may be in-
voked through its ability to stimulate IFN-g, which inhibits the
parasite (23). Furthermore, IL-12 is also a key cytokine mod-
ulating the endotoxin-induced inflammatory process in mice
(13). Metzger et al. have suggested that IL-12 augments the
natural immune response due to innate or inflammatory com-
ponents of the host defense system prior to the development of
the humoral or cellular immune response (19). This initial
response may be important in bacterial meningitis since cere-
brospinal fluid (CSF) defense mechanisms against infection
are limited.
We questioned whether IL-12 is involved in the early phase
of the inflammatory response in the CSF of children with
bacterial meningitis. For this purpose, we studied the presence
of IL-12 and its relation to other proinflammatory (TNF-a,
IL-6, IL-8, and IFN-g) as well as anti-inflammatory (IL-10)
cytokines in serum and CSF of 35 children with bacterial men-
ingitis.
MATERIALS AND METHODS
Patients and controls. Patients between the ages of 3 months and 18 years who
were diagnosed with bacterial meningitis between August 1992 and September
1994 were eligible for inclusion. The patients were admitted to the Departments
of Pediatrics of the Sophia Children’s Hospital and Zuiderziekenhuis, both in
Rotterdam, Reinier de Graaf Gasthuis in Delft, and Juliana Children’s Hospital
in The Hague. Bacterial meningitis was defined as the presence of a positive
bacterial culture from CSF or the presence of a positive blood culture in com-
bination with clinical evidence of meningitis and a CSF leukocyte (WBC) count
above 10 3 106/liter. Patients with prior antibiotic treatment were excluded.
Paired control samples of serum and CSF were obtained from 10 pediatric cancer
patients who were in remission. The lumbar punctures in these children were
done for diagnostic reasons. CSF samples from patients and controls were
examined for WBC count and levels of glucose and protein.
The Medical Ethics Committee of each of the participating centers approved
the study protocol. Written informed consent was obtained from the children’s
parents or legal representatives.
Collection of samples. Samples of blood and CSF were obtained on admission
prior to the initiation of antibiotic treatment. Blood was collected into sterilized
siliconized Vacutainer glass tubes (Becton Dickinson, Meylan Cedex, France)
and allowed to clot at room temperature. CSF samples were collected into
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pyrogen-free polystyrene tubes (Falcon; Becton Dickinson, Franklin Lakes,
N.J.). The samples were centrifuged at 2,800 3 g at 48C for 10 min. The
supernatants were stored at 2708C until used for different assays. Samples were
never thawed and refrozen before assay.
Laboratory studies. Cultures of blood and CSF were processed according to
standard procedures (15). The CSF WBC count and the glucose and protein
concentrations were determined by routine laboratory procedures in each of the
participating hospitals.
(i) IL-12 p40. IL-12 p40 antigen was measured with an enzyme-linked immu-
nosorbent assay (ELISA) as described previously (29). Results were related to a
dose-response curve of recombinant IL-12 p40 and expressed as picograms per
milliliter. The lower limit of sensitivity was 50 pg/ml.
(ii) IL-12 p70. IL-12 p70 antigen was measured by using an ELISA with
monoclonal antibody (MAb) 20C2, which preferentially reacts with IL-12 p70,
and MAb C8.6, which reacts with IL-12 p40 and p70 antigens equally well (9).
Concentrations of p40 antigen of up to 20 ng per ml were not detected by this
ELISA. Observations in septic baboons showed a good correlation (r 5 0.87)
between results obtained with this ELISA and a bioassay for IL-12 (16). Recom-
binant human IL-12 p70 was used as a standard. The lower limit of sensitivity of
this assay was 2.5 pg/ml.
(iii) IFN-g. IFN-g was measured by using an ELISA obtained from the De-
partment of Immune Reagents, Central Laboratory of The Netherlands Red
Cross Blood Transfusion Service, according to the manufacturer’s instructions.
The lower limit of sensitivity of this assay was 10 pg/ml.
(iv) TNF-a, IL-6, IL-8, and IL-10. Serum and CSF levels of TNF-a, IL-6, IL-8,
and IL-10 were measured with ELISA kits (Medgenix, Fleurus, Belgium) ac-
cording to the manufacturer’s instructions with the following detection limits
(lowest positive standard): TNF-a, 15 pg/ml; IL-6, 30 pg/ml; IL-8, 7 pg/ml; and
IL-10, 11 pg/ml.
Statistical analysis. Differences between groups in continuous variables were
tested for significance with the Mann-Whitney test. Differences in frequencies of
findings between groups were analyzed by Fisher’s exact test. Pairwise compar-
isons regarding the percentage of CSF levels above the detection limit were
assessed with McNemar’s test. The Spearman correlation coefficient (r) was used
to evaluate the relation between specific variables. Two-tailed P values of #0.05
were considered significant.
RESULTS
Patients and controls. The clinical and laboratory charac-
teristics of patients and control subjects are shown in Table 1.
Thirty-five patients with a proven bacterial meningitis were
enrolled. CSF samples from the controls were sterile and
showed normal characteristics. Chemotherapy had been dis-
continued in all of the control subjects for at least 3 months.
None of the control subjects underwent craniospinal irradia-
tion or bone marrow transplantation. The controls were still in
remission at the next follow-up visit. The median age (range)
of the children in the control group was significantly higher
than that of the patients (9.1 years [4.1 to 17.9 years] versus 1.8
years [0.3 to 13.0 years]; P , 0.001).
IL-12 and IFN-g in serum and CSF samples on admission.
The biologically active form of IL-12 p70 was detected in CSF
in 2 (6%) of the 35 patients on admission, while the subunit
p40 of IL-12 was detectable in 28 (80%) of the 35 patients with
bacterial meningitis. CSF levels of IL-12 p40 and p70 were
below the detection limit in all 10 control subjects. The per-
centage of detectable CSF levels of IL-12 p40 in the patients
was significantly higher than in control subjects (P , 0.001). In
contrast, CSF levels of IL-12 p70 were not different between
patients and control subjects.
CSF levels of IFN-g were above the detection limit in 20
(57%) of the 35 patients with bacterial meningitis, whereas
none of the control subjects had detectable IFN-g levels (P ,
0.001).
Pathogen-dependent differences in CSF levels of cytokines.
The pathogen-dependent CSF levels of TNF-a, IL-12, IFN-g,
and IL-10 and the TNF-a/IL-10 ratios are shown in Table 2.
Children with meningitis caused by Haemophilus influenzae or
Streptococcus pneumoniae had comparably high CSF levels of
IL-12 p40 (median, 503 pg/ml versus 509 pg/ml; P5 0.50). CSF
levels of IL-12 p40 were lowest in patients with meningococcal
meningitis (median, 86 pg/ml). Detectable CSF levels of IFN-g
were observed significantly more frequently in patients with
pneumococcal meningitis than in children with meningitis due
to H. influenzae and Neisseria meningitidis. Pathogen-depen-
dent differences in CSF levels of TNF-a and IL-10 were not
observed. The CSF ratio of TNF-a to IL-10 was significantly
higher in patients with pneumococcal meningitis than in chil-
dren with meningitis caused by H. influenzae and N. meningi-
tidis. Comparisons between the TNF-a/IL-10 ratio of H. influ-
enzae against those of the other two pathogens and of the
TNF-a/IL-10 ratio of N. meningitidis against those of the other
two pathogens did not yield significant results.
Serum versus CSF levels of IL-12 and IFN-g on admission.
Paired samples of CSF and serum were obtained from 20
patients with bacterial meningitis. The median (range) serum
levels of IL-12 p40 were comparable to those of control sub-
jects (165 pg/ml [72 to 1042 pg/ml] versus 109 pg/ml [59 to 299
TABLE 1. Clinical and laboratory characteristics of 35 children with bacterial meningitis and 10 control subjects
Group Median age(yr) (range)
Gender (no.) Microorganism (no.) Median value in CSF (range)





Patients (n 5 35) 1.8 (0.3–13.0) 15 20 15 13 6 1 3,330 (15–34,000) 1.7 (,0.1–5.3) 1.5 (0.2–8.0)
Controls (n 5 10) 9.1 (4.1–17.9) 5 5 1 (0–2) 3.0 (2.7–3.5) 0.3 (0.3–0.6)
TABLE 2. CSF levels of TNF-a, IL-12, IFN-g, and IL-10 and the ratios between TNF-a and IL-10 in patients with pneumococcal















H. influenzae and N. meningitidis (n 5 28) 414 (,15–10,600) 2 (7) 358 (,50–11,936) 13 (46) 654 (,10–4,000) 0.9 (0.2–117.5)
S. pneumonia (n 5 6) 2,324 (355–4,631) 0 (0) 509 (,50–5,390) 6 (100) 736 (109–1,694) 2.1 (1.5–30.3)
P 0.08b 1.0c 0.55b 0.02c 0.98b 0.04b
aMedian (range) or number of cases above threshold (%).
bMann-Whitney test.
c Fisher exact test.
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pg/ml]; P 5 0.52). The proportions of detectable serum levels
of IL-12 p70 and IFN-g were also comparable between pa-
tients and control subjects (for IL-12 p70, 2 of 20 [10%] versus
0 of 10 [0%] [P 5 0.54]; for IFN-g, 6 of 20 [30%] versus 1 of
10 [10%] [P 5 0.37]).
Detectable concentrations of IL-12 p40 in CSF on admission
occurred more often than in corresponding serum samples
(P 5 0.03, McNemar test), whereas those of IL-12 p70 and
IFN-g in serum and CSF were not significantly different (Fig.
1).
Correlation between IL-12 and IFN-g, TNF-a, IL-6, IL-8,
and IL-10 and other characteristics of CSF on admission. CSF
levels of IL-12 p40 on admission correlated with those of
TNF-a (r 5 0.49, P 5 0.004), IL-6 (r 5 0.42, P 5 0.02), and
IL-10 (r5 0.61, P, 0.001) and detectable CSF levels of IFN-g
(r 5 0.51, P 5 0.02) but not with those of IL-8 (r 5 0.18, P 5
0.16). Interestingly, detectable CSF concentrations of IFN-g
on admission correlated only significantly with CSF levels of
IL-12 p40 (r5 0.51, P5 0.02) and TNF-a (r5 0.48, P5 0.04),
as shown in Fig. 2. CSF WBC count and glucose and protein
concentrations were significantly correlated with CSF levels of
IL-12 p40 (r5 0.40 and P5 0.02, r5 20.69 and P, 0.001, and
r 5 0.35 and P 5 0.05, respectively). In contrast, CSF levels of
IFN-g were not associated with any of these CSF characteris-
tics.
DISCUSSION
IL-12 is produced by phagocytic cells in response to infection
and stimulates adaptive immunity by selectively inducing the
Th1 cytokine pattern (IL-2 and IFN-g) (21, 24). Furthermore,
it induces production of IFN-g and TNF-a and activates the
cytotoxic activity of NK cells (2, 5, 27). IFN-g in turn enhances
the function of macrophages and polymorphonuclear leuko-
cytes by stimulating nonspecific defense mechanisms such as
phagocytosis and secretion of reactive oxygen intermediates
(20). Together, these responses contribute to innate host de-
fense systems against invading microorganisms and are usually
effective in reducing the load of infection. Our findings suggest
that such a host defense mechanism involving IL-12 and IFN-g
operates in the CSF compartments of patients with bacterial
meningitis.
In this study, CSF levels of IL-12 p40 in patients with bac-
terial meningitis were much higher than those of IL-12 p70.
This finding is in agreement with the observation that p40 is
released in excess to the bioactive protein (p70) (9, 26). Al-
though CSF levels of IL-12 p70 were below the detection limit
(,2.5 pg/ml) in most patients, this not necessarily rule out the
presence of IL-12 since biologic activity of IL-12 such as en-
hancement of NK cell cytotoxicity has been reported in the
FIG. 1. Serum and CSF concentrations of IL-12 p40 and IFN-g on admission
in 20 patients with bacterial meningitis. The broken line indicates the detection
limit.
FIG. 2. Correlation between admission CSF levels of IFN-g and IL-12 p40
(A) and TNF-a (B) in children with bacterial meningitis. Horizontal and vertical
lines indicate the detection limits.
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presence of concentrations below 1 pM (6, 17). Furthermore,
bioactive IL-12 may have escaped detection by binding to spe-
cific receptors on cells. CSF levels of IFN-g were also elevated
in our patients with bacterial meningitis, as was previously
observed by others (7, 12, 22, 25). The levels of IL-12 p40 were
significantly higher in the CSF compartment than in serum,
implicating intrathecal production. Our results do not allow
conclusions regarding the cellular source of IL-12 in the CSF
compartment.
We observed a significantly positive correlation between
CSF levels of IL-12 p40 and IFN-g, TNF-a, IL-6, and IL-10. In
vitro studies suggest that these cytokines may not be respon-
sible for the secretion of IL-12 (9). Thus, these correlations
likely reflected a common stimulus, i.e., the microorganisms or
their products. Experimental data indicate that IL-12 is re-
quired for IFN-g production. This is confirmed by the obser-
vation that IL-12 circulates in the serum before the appearance
of IFN-g (13, 32). Furthermore, pretreatment with anti-IL-12
antibodies inhibits production of IFN-g in response to a chal-
lenge by endotoxin. IL-12 is not the only cytokine needed to
induce the release of IFN-g. In the SCID model of listeriosis,
TNF-a is an important cofactor for IFN-g production by NK
cells in vivo (3) and in vitro (3, 30). However, TNF-a by itself
is unable to induce IFN-g production. Neutralization of TNF-a
with monoclonal antibodies inhibits NK cell IFN-g production
in vitro and inhibits macrophage activation in vivo, resulting in
increased systemic bacterial spread (3). Furthermore, the re-
lease of IFN-g is inhibited by IL-10, which prevents production
of IL-12 and of the costimulatory cytokines IL-1b and TNF-a
by accessory cells (8). These data together explain that CSF
levels of IFN-g in our patients were associated only with IL-12
and a possible costimulator, TNF-a. Thus, both IL-12 and
TNF-a were probably responsible for the production of IFN-g
in the subarachnoid spaces of patients with bacterial meningi-
tis.
Interestingly, patients with pneumococcal meningitis had
significantly higher CSF levels of IFN-g in comparison with
those with meningitis due to H. influenzae and N. meningitidis,
as was previously observed by others (12). This observation
cannot be explained by an increased IL-12 production since
CSF levels of IL-12 were not markedly higher in patients with
pneumococcal meningitis. However, the high CSF ratio be-
tween the costimulator TNF-a and IL-10, which inhibits IL-
12-induced IFN-g production, in the patients with pneumococ-
cal meningitis in comparison to those with meningitis due to
other pathogens may provide an explanation for the higher
CSF levels of IFN-g in patients with pneumococcal meningitis.
We conclude that the production of IFN-g in the CSF com-
partments of patients with bacterial meningitis is at least partly
induced by IL-12, with TNF-a as a costimulator. We suggest
that IL-12-induced IFN-g release may contribute to the local
host defense in the subarachnoid space against bacterial men-
ingitis.
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